Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Donor transmitted malignancies.

Joseph F Buell1, Thomas M Beebe, Jennifer Trofe

  • 1The Israel Penn International Transplant Tumor Registry, Department of Surgery, University of Cincinnati, Cincinnati, Ohio 45267-0558, USA. joseph.buell@uc.edu

Annals of Transplantation
|October 14, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression.

Progress in transplantation (Aliso Viejo, Calif.)·2026
Same author

Patient-reported Opioid use and Pain Management After Living Kidney Donation.

Transplantation direct·2026
Same author

Be a Limitless Pharmacist: Remarks by the 2025 Paul F. Parker Medalist.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Risk factor analysis of 115 children and adolescents with primary mediastinal B-cell lymphoma treated with DA-EPOCH-R.

Blood advances·2026
Same author

Tolerability and Effectiveness of Tirzepatide in Kidney Transplant Recipients: Real-world Experience From a Single-center Study.

Transplantation·2026
Same author

Erratum: Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Comparison of Health-Related Quality of Life After Pure Laparoscopic vs Open Donor Hepatectomy in a Low-Volume Living Donor Liver Transplantation Center: A Retrospective Cohort Study.

Annals of transplantation·2026
Same journal

Development and Validation of an Early Post-Liver Transplant Activity Knowledge, Attitude, and Practice Questionnaire for Intensive Care Unit Nurses: A Multicenter Study.

Annals of transplantation·2026
Same journal

Opioid-Sparing Effects of Peripheral Nerve Blocks in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis.

Annals of transplantation·2026
Same journal

Brain Death-Induced Systolic Ventricular Dysfunction and Its Association With NLRP3-Related Inflammatory Signaling in a Murine Model.

Annals of transplantation·2026
Same journal

Development and Internal Validation of a Web-Based Dynamic Nomogram for Dynamic Risk Stratification of Early Bacterial Infection in Liver Transplant Recipients.

Annals of transplantation·2026
Same journal

A New Lifeline: Feasibility and Outcomes of Altruistic Donor Programs in Living-Donor Liver Transplantation, A Single Saudi Center Experience.

Annals of transplantation·2026
See all related articles

Transplanting organs from donors with cancer can transmit malignancy to recipients. This study analyzed registry data to understand transmission risks and identify factors to minimize future donor-transmitted cancers in organ recipients.

Area of Science:

  • Transplantation Medicine
  • Oncology
  • Public Health

Background:

  • Historically, organs from donors with active malignancies were used in transplantation.
  • This practice led to occasional transmission of cancer from donor to recipient.
  • Improved transplant survival has increased organ demand, leading to the use of marginal donors, some with undiagnosed malignancies.

Purpose of the Study:

  • To examine the distribution of donor-transmitted malignancies reported to the Israel Penn International Transplant Tumor Registry.
  • To investigate the incidence of tumor transmission across different histologies.
  • To identify factors associated with malignancy transmission risk to minimize future occurrences.

Main Methods:

  • Analysis of voluntary registry data from the Israel Penn International Transplant Tumor Registry.

Related Experiment Videos

  • Cataloguing approximately 250 cases of organ transplants from donors with a history of malignancy over three decades.
  • Examination of tumor histology, donor risk factors, tumor presentation, and recipient outcomes.

    • Main Results:

    • Some recipients developed cancers suspicious for donor origin, while others remained cancer-free.
    • Central nervous system malignancies are frequently identified in potential donors.
    • Registry data, though voluntary, offers insight into transmissions from high-risk donors.

    Conclusions:

    • Understanding donor malignancy transmission is crucial for recipient safety.
    • Identifying risk factors can help mitigate the transmission of tumors from donors to recipients.
    • Continued surveillance and registry data analysis are vital for improving transplant safety.